Dare Bioscience, Inc. DARE 深 沪
交易中 06-26 12:06:42 美东时间
2.045
+0.045
+2.25%
华盛通- 最 高2.08
- 今 开2.00
- 成交量 1.47万股
- 最 低 1.99
- 昨 收 2.00
- 总市值 3063.31万
- 52周最高 9.19
- 市盈率 静 --
- 换手率 0.10%
- 52周最低 1.27
- 委 比 -15.11%
- 总股本 1497.95万
- 历史最高 76.44
- 量 比 0.25
- 振 幅 4.50%
- 历史最低 1.27
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dare Biosciences Receives Second $1M Tranche Of NIH Funding
Receipt of award notice for second $1.0 million tranche of NIAID funding brings total NIH funding award for DARE-HPV to $2.0 millionFunding award milestone follows Daré's announcement last week of the initiation of its
05-26 20:15
电话会总结 ｜ Daré(DARE)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Daré Bioscience业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **现金状况：** - 截至季度末现金及现金等价物约1,850万美元 - 营运资金约50万美元 **费用支出：** - 销售、一般及管理费用（SG&A）：220万美元 - 研发费用（R&D）：70万美元 - 实际研发投资（加回抵消研发费用后）：约420万美元（70万美元 + 350万美元抵消金额） **非稀释性资金：** - 2025年获得：盖茨基金会1,360万美元、ARPA-H奖励450万美元、NIH报销130万美元 - 2026年2月获得：ARPA-H
05-16 12:30
Dare Bioscience Q1 2026 Earnings Call: Complete Transcript
Dare Bioscience (NASDAQ:DARE) released first-quarter financial results and host...
05-15 05:37
Dare Bioscience Q1 EPS $(0.20) Beats $(0.27) Estimate, Sales $152.455K Miss $984.667K Estimate
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.27) by 25.93 percent. This is a 60 percent increase over losses of $(0.50) per share from the
05-15 04:04
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Dare Bioscience Announces Interim Safety And Efficacy Results From Phase 3 Clinical Trial Of Ovaprene
Second Positive DSMB Review Supports Continued Study ProgressInterim Phase 3 Results Support Ovaprene's Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly Contraceptive
05-12 20:06
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...
04-17 05:05
Dare Bioscience Q4 EPS $(0.02) Beats $(0.43) Estimate, Sales $1.024M Beat $375.750K Estimate
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.43) by 95.37 percent. This is a 96.92 percent increase over losses of $(0.65) per share from
03-27 04:05
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Daré Bioscience Gets ~$2M Funding From National Institutes Of Health's Division For Its Intravaginal Ring DARE-PTB1 For Prevention Of Preterm Birth
Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced receipt of a revised
03-16 20:08
